Sort
39,280 grants matching “leukemia”
Targeting NSD1 in leukemia
$472,928Tomasz Cierpicki · University Of Michigan At Ann Arbor · R01 · FY2020 · CA
Project 2: Targeting signaling networks to overcome therapeutic resistance in pancreatic cancer
$472,698Tony R. Hunter · Salk Institute For Biological Studies · P01 · FY2024 · CA
A novel miR-198 replacement therapy for pancreatic cancer
$472,669Qizhi C. Yao · Baylor College Of Medicine · R01 · FY2015 · CA
FANCD2 interaction with mismatch repair proteins and MCM2-7
$472,668Gary M. Kupfer · Yale University · R01 · FY2013 · HL
Epigenetics of Development
$472,608Brant Weinstein · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2019 · HD
Next-generation genetic engineering of the pan-leukocyte antigen CD45 to facilitate CAR-T cell therapy against hematologic malignancies
$472,594Saar Gill · University Of Pennsylvania · P01 · FY2023 · CA
RNAi Analysis and Screening for Study of Genes and Anti-Cancer Treatments
$472,578Natasha Caplen · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Determinants of Architecture on Retroviral Intasome Mechanics
$472,500Kristine E Yoder · Ohio State University · R01 · FY2024 · GM
Determinants of Architecture on Retroviral Intasome Mechanics
$472,500Kristine E Yoder · Ohio State University · R01 · FY2025 · GM
Determinants of Architecture on Retroviral Intasome Mechanics
$472,500Kristine E Yoder · Ohio State University · R01 · FY2023 · GM
SOUTHWEST ONCOLOGY GROUP
$472,474University Of Rochester · U10 · FY2001 · CA
MOLECULAR PATHOLOGY OF LYMPHOID MALIGNANCIES
$472,306Stanford University · R37 · FY2000 · CA
Credentialing murine models for glioblastoma preclinical drug development
$472,269Christopher Ryan Miller · University Of Alabama At Birmingham · R01 · FY2019 · CA
Core B: Biostatistics and Data Management
$472,259Ted Gooley · Fred Hutchinson Cancer Center · P01 · FY2025 · CA
Core B: Biostatistics and Data Management
$472,259Ted Gooley · Fred Hutchinson Cancer Center · P01 · FY2024 · CA
Human Leukemia Growth Inhibition by a Novel Retinoid
$472,239Wayne State University · R01 · FY2004 · CA
HMGA Chromatin Remodeling Proteins in Tumor Progression in Myeloproliferative Neoplasms (MPN)
$472,224Linda M S Resar · Johns Hopkins University · R01 · FY2021 · HL
New Gene Regulatory Proteins Regulating Erythroid Development
$472,214Harvey F Lodish · Boston Children'S Hospital · P01 · FY2014 · HL
Lifecourse determinants and outcomes of epigenetic age acceleration across two generations
$472,163Christopher Kuzawa · Northwestern University · R01 · FY2022 · AG
Therapeutic Elimination of Stem Cells for Relapsed Pediatric AML
$472,123Yang Liu · Children'S Research Institute · U01 · FY2016 · CA
Genetic susceptibility to unrelated donor stem cell transplant-related mortality
$472,096Theresa E Hahn · Roswell Park Cancer Institute Corp · R01 · FY2013 · HL
Drug resistant pathways in relapsed acute lymphoblastic leukemia (ALL)
$472,074William L. Carroll · New York University School Of Medicine · R01 · FY2016 · CA
Training Program in Molecular Hematology
$472,064Grover Carlton Bagby · Oregon Health & Science University · T32 · FY2010 · HL
Delayed Regulation of GVHD with Retained GVL Effect
$472,051Robert Korngold · Dana-Farber Cancer Inst · U19 · FY2009 · AI
Comparative Analysis of Genetic Interaction Networks
$472,015Trey Ideker · University Of California, San Diego · R01 · FY2016 · GM